LYNPARZA (OLAPARIB) — FDA Approval NDA208558 (ASTRAZENECA)
LYNPARZA (OLAPARIB) — FDA Approval NDA208558 (ASTRAZENECA) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: LYNPARZA; Active ingredients: OLAPARIB; Application number: NDA208558.
| Brand name | LYNPARZA |
|---|---|
| Active ingredients | OLAPARIB |
| Application number | NDA208558 |
| Sponsor | ASTRAZENECA |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 2 |
| First approval date | 20170817 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →